Crucell Acquires Berna Products Corp.
Dutch biotechnology company Crucell N.V. (Leiden, The Netherlands, www.crucell.com) has purchased Florida-based Berna Products Corp. from Acambis.
Dutch biotechnology company Crucell N.V. (Leiden, The Netherlands, www.crucell.com) has purchased Florida-based Berna Products Corp. from Acambis. Crucell is a biotechnology company focused on R&D and marketing vaccines and antibodies that prevent and treat infectious diseases. Berna Products was formed to market Vivotif, an oral typhoid fever vaccine, in the US and Canada. The company was acquired by Acambis in 2003.
Novartis Acquisition of Regulus Therapeutics is Complete
June 25th 2025A key property included in the acquisition is farabursen, an investigational next-generation oligonucleotide targeting the microRNA miR-17 with preferential kidney exposure, intended to treat people with autosomal dominant polycystic kidney disease.
